Omicron variant resembles other respiratory viruses, posing challenges for syndromic surveillance

Researchers describe the symptom profiles of respiratory viral infections.

Methadone clinics spar with addiction doctors on bill that would widen access

Lawmakers on Tuesday will debate an addiction medicine proposal that would have been considered unthinkable just years ago: giving a select group of doctors the

December 12, 2023

Erasca’s ERAS-801 secures FDA orphan drug designation

Erasca’s ERAS-801 will be used to treat malignant glioma, including glioblastoma. Credit: Nemes Laszlo / Shutterstock.com. Erasca has obtained orphan drug designation (ODD) from the

June 23, 2023

City Therapeutics launches with $135m Series A funding

City Therapeutics is developing an siRNA-engineering platform to design, enhance, and optimise RNAi-based medicines. Credit: PeopleImages.com – Yuri A/Shutterstock. City Therapeutics has announced its launch,

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.